Funding · Company
MapLight Therapeutics, Inc.
Redwood City, CABiotech & Pharma
MapLight Therapeutics, Inc. of Redwood City, CA has disclosed $293M across 2 Form D offerings filed with the SEC between Nov 3, 2023 and Jul 28, 2025.
$293M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$188M
Form D · Jul 28, 2025 ↗
Q3 2025
· target $372M
$105M
Form D · Nov 3, 2023 ↗
Q4 2023
· 1 amendment, first filed Jul 19, 2023
· target $225M
Filing details
HeadquartersRedwood City, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001770069Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →